Adults 15 to 19, any sex, with HIV/AIDS or Adolescent Behavior. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Percentage of Active Members Who Have at Least One Post in Group Chat Session.Primary· 3 months
Participants level of engagement in support group activities informs on the feasibility of intervention, measured by percentage of active members who have at least one post in group chat session.
Group
Value
95% CI
Online Support Group
32
Acceptability ScoreSecondary· 3 months
Acceptability score: A set of ten items asking if participants agreed=1 or disagreed=0 with statements on acceptability. Score represents a sum of the 10 items with a range of 0 to 10, and a greater number indicating agreement with more acceptability items.
Group
Value
95% CI
Online Support Group
9.9
9 – 10
Adherence to ART as Measured by the AACTG Adherence AssessmentSecondary· 3 months
Proportion of participants who report not having missed any ART doses in past 3 days.
Group
Value
95% CI
Online Support Group
29
Adherence to Follow-up Visit Within 1 Month of Scheduled DateSecondary· 3 months
Retention in HIV services will be measured using data abstracted from the medical record system on date of visits between enrollment and the endline of this study. To be considered retained in HIV services, an individual must, at 3 months after enrollment, have attended his/her most recently scheduled clinical follow-up visit within 1 month of the date when it was scheduled to take place.
Group
Value
95% CI
Online Support Group
37
Sponsor's own description
This study will examine the feasibility and acceptability of an intervention designed to improve retention in HIV care services and improve anti-retroviral therapy (ART) adherence among adolescents ages 15-19 years living with HIV enrolled in ART services.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT06741618 — MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
· NA
· recruiting
NCT07298785 — Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot Study
· NA
· recruiting
NCT07072481 — Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing
· NA
· recruiting
NCT07064785 — Video-Intervention to Inspire Treatment Adherence for Life for Adolescents
· NA
· recruiting
NCT07074899 — Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru
· NA
· active not recruiting
Other FHI 360 trials
Trials by the same sponsor.
NCT05233956 — Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya
· NA
· active not recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by FHI 360
Last refreshed: 5 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03076996.